Pfizer Inc. (NYSE:PFE) Shares Bought by WASHINGTON TRUST Co

Lloyd Doyle
November 28, 2017

Bank of Nova Scotia now owns 1,934,514 shares of the biopharmaceutical company's stock valued at $66,180,000 after purchasing an additional 1,480,258 shares during the last quarter. Bankunited Inc now has $3.79B valuation. The stock rose 0.13% or $0.04 reaching $35.53 per share. About 277,017 shares traded. Timberland Bancorp, Inc. (TSBK) has risen 56.96% since November 27, 2016 and is uptrending. It has underperformed by 99.83% the S&P500.

Matrix Asset Advisors Inc increased Pfizer Inc. Kings Point Capital Management sold 9,761 shares as Pfizer Inc Com (PFE)'s stock declined 3.45%. That value represents a market adjusting for revenues that have been growing by 0.94 % on a quarterly year/year basis as of the company's last quarterly report.

Pfizer Inc. (PFE) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers - Major. (NYSE:PFE) for 355,251 shares. (NYSE:PFE) by 2.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). It has underperformed by 19.46% the S&P500.

Investors sentiment increased to 1.26 in 2017 Q2. Its down 0.01, from 0.95 in 2017Q1. It fall, as 58 investors sold PFE shares while 716 reduced holdings. 112 funds opened positions while 612 raised stakes. Girard holds 94,701 shares or 0.69% of its portfolio. Toronto Dominion Financial Bank has 2.11M shares.

Shares of Pfizer Inc. (NYSE:PFE). 130,990 are owned by Palisade Cap Management Ltd Co Nj. Sumitomo Mitsui Inc reported 0.88% stake. 1,247 were accumulated by Tower Rech Limited Com (Trc). Wellington Mgmt Grp Limited Liability Partnership holds 70.05M shares. Condor Capital Mngmt has 0.67% invested in Pfizer Inc. (NYSE:PFE) to report earnings on January, 30.

Now that you have insight into the fundamentals of Pfizer Inc., begin taking a look at the technical patterns of the stock chart. (NYSE:PFE) for 36,550 shares. JPMORGAN CHASE & CO also announced increased position in Pfizer Inc. They expect $0.55 EPS, up 17.02% or $0.08 from last year's $0.47 per share. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.86% with $5.95 Billion sitting short, betting on future declines. Pfizer's quarterly revenue was down 1.7% compared to the same quarter a year ago. Boston Partners grew its stake in shares of Pfizer by 7.3% in the 1st quarter. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and thirteen have given a buy rating to the company's stock. Therefore 43% are positive. As per Monday, August 1, the company rating was maintained by BNP Paribas. Stock on Your Watchlist" published on November 17, 2017, published: "Pfizer, Inc. (NYSE:PFE) have caught the attention of investors. The rating was maintained by Liberum Capital with "Buy" on Monday, February 1. ValuEngine raised shares of Pfizer from a "hold" rating to a "buy" rating in a report on Friday, October 6th. Jefferies has "Hold" rating and $3500 target. The rating was maintained by BMO Capital Markets with "Buy" on Tuesday, November 21. The firm has "Hold" rating given on Thursday, July 13 by Jefferies. The company was upgraded on Tuesday, October 20 by Cowen & Co. About 6.40M shares traded. It also upped Lennar Corp. (NYSE:T) or 6,458 shares. Therefore 20% are positive. AT&T Inc. had 67 analyst reports since July 27, 2015 according to SRatingsIntel. Also, insider Alexander R. Mackenzie sold 14,700 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock of Hyatt Hotels Corporation (NYSE:H) earned "Underperform" rating by CLSA on Wednesday, November 2. Finally, Morgan Stanley upgraded Pfizer from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $35.00 to $39.00 in a research note on Wednesday, September 20th. The ex-dividend date of this dividend is Thursday, November 9th. The firm earned "Neutral" rating on Friday, December 2 by Guggenheim. The rating was maintained by Piper Jaffray with "Buy" on Wednesday, August 2. BidaskClub upgraded shares of Pfizer from a "strong sell" rating to a "sell" rating in a research report on Saturday, August 5th. The company was maintained on Friday, April 28 by BMO Capital Markets. $38.62's average target is 8.82% above currents $35.49 stock price. The firm has "Outperform" rating given on Tuesday, January 19 by Hovde Group.

Shares of U.S. Global Investors, Inc. DLPX's SI was 100 shares in November as released by FINRA. Deutsche Commercial Bank Ag reported 0.02% in BankUnited (NYSE:BKU). Huntington Bank & Trust invested in 1,213 shares. Roundview Cap Limited holds 0.64% of its portfolio in Pfizer Inc. Perennial Advisors LLC now owns 5,132 shares of the biopharmaceutical company's stock worth $172,000 after acquiring an additional 376 shares during the last quarter. Moreover, Sonata Cap has 0.46% invested in AT&T Inc. Grandfield & Dodd LLC raised its holdings in shares of Pfizer by 0.3% during the first quarter. Balyasny Asset Lc stated it has 7,196 shares or 0% of all its holdings. Magnetar Fincl Ltd invested in 0% or 6,291 shares. The percentage of shares being held by the company management was 3.2% while institutional stake was 39.3%.

Analysts await Pfizer Inc. It closed at $0.0061 lastly. BKU's profit will be $65.12 million for 14.55 P/E if the $0.61 EPS becomes a reality. Analysts are forecasting earnings of $0.56 on a per share basis this quarter.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article